rs756074244
- Uncertain significance
Your Genotype
Sign InDescription
The p.T1072A variant (also known as c.3214A>G), located in coding exon 19 of the BRIP1 gene, results from an A to G substitution at nucleotide position 3214. The threonine at codon 1072 is replaced by alanine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
This missense variant replaces threonine with alanine at codon 1072 of the BRIP1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 1/251370 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Reference Allele
T
Alternative Allele
C
Chromosome
17
Location
61683832
Variant Type
SNP
Genes
ClinVar
Name
NM_032043.3(BRIP1):c.3214A>G (p.Thr1072Ala)
Allele
C
Clinical Significance
Uncertain significance